Site icon Healthcare, Lifestyle, Entertainment, Living and Travel

Cigna PBM Express Scripts to remove Humira from many formularies


JHVEPhoto/iStock Editorial through Getty Images

  • AbbVie’s Humira (adalimumab) can be taken off the formulary lists of many Cigna (NYSE:CI) well being care plans in 2025 in favor of cheaper biosimilar model.
  • Members subsequent 12 months can get Simlandi from Teva (TEVA) and Alvotech (ALVO), Cyltezo from BoehringerNVS



Source: Seekingalpha

Exit mobile version